T cells are commonly referred to be "assassins" or "killers" because they can plan and execute missions to hunt down bacteria, viruses, and cancer cells throughout the body. As powerful as T cells may be, current research has revealed that once they enter the environment of a solid tumour
Researcher Paul Dent of Virginia Commonwealth University's Department of Biochemistry and Molecular Biology found that tumours that have metastasized to distant locations, such as the brain, are most often impossible to treat and cure, despite recent successes in some tumour types such as NS
Lung cancer is not the most frequent type of cancer, but it is by far the most deadly. Despite therapies such as surgery, radiation therapy, and chemotherapy, only about a quarter of all persons with the disease will live more than five years following diagnosis, and the World Health Organiz
Mumbai (Maharashtra) [India], February 15: Glenmark Pharmaceuticals Ltd. (Glenmark), a research-led, global pharmaceutical Company, today announced its financial results for the third quarter ended December 31, 2023.
Lung adenocarcinoma is the most common type of lung cancer, accounting for the majority of cancer-related fatalities in the US. There are various causes of lung adenocarcinoma, one of which is a mutation in a protein known as EGFR. Non-mutant EGFR stimulates cell proliferation in response to
Mumbai (Maharashtra) [India], January 31: Glenmark Pharmaceuticals Ltd. (Glenmark), a leading, research-driven, global pharmaceutical company, and Ichnos Sciences Inc. (Ichnos), its global fully integrated, clinical-stage biotech subsidiary, today announced the launch of their alliance - Ich
A recent study indicated that children who develop neuroblastomas, a rare type of cancer that starts in nerve cells, may benefit from getting particular anti-tumor medications in addition to chemotherapy
Water cycling across membrane transporters is a characteristic of cell metabolism and has the potential to be very diagnostic in the characterisation of tumours and other illnesses.
Researchers at Mount Sinai's Icahn School of Medicine have discovered an allergy route that, when inhibited, activates antitumor immunity in animal models of non-small cell lung cancer (NSCLC).
A revolutionary study performed by UNIST's Department of Biological Sciences' Professor Sebyung Kang and Professor Sung Ho Park has shown a significant advance in cancer therapy. The study team has successfully generated novel "NK cell-engaging nanodrones" capable of specifically targeting